Research Article

Chronic Kidney Disease and Mortality in Implantable Cardioverter-Defibrillator Recipients

Table 1

Characteristics of the study population. Groups based on eGFR or being on hemodialysis.

GFRESRD on
60 mL/min 60 mL/minhemodialysis
( )( )( ) -test or
CharacteristicsMean SE or % ( )

Age (yr) .0005
Male Gender78.6 (202)75.9 (123)68.2 (15)NS
Caucasian Race72.0 (185)82.7 (134)72.7 (16).041
Hypertension70.8 (182)70.8 (114)90.9 (20)NS
Diabetes Mellitus28.8 (74)27.2 (44)54.5 (12).028
Ischemic Heart Disease77.0 (151)83.2 (109)88.9 (16)NS
Ejection Fraction (%)26.6 ± 0.825.2 ± 0.825.0 ± 2.6NS
eGFR (mL/min)93.6 ± 2.044.7 ± 0.810.3 ± 0.4 .0005
Creatinine (mg/dl)1.02 ± 0.021.52 ± 0.047.14 ± 0.30 .0005
Magnesium (mg/dl)1.75 ± 0.021.77 ± 0.022.01 ± 0.5 .0005
Potasium (mEq/L)4.16 ± 0.034.28 ± 0.434.68 ± 0.14 .0005
Amiodarone15.6 (40)18.5 (30)40.9 (9).012
Atrial fibrillation19.8 (51)28.4 (46)36.4 (8).049
DFT > 20 Joules35.3 (88)27.7 (43)66.7 (2).129
Beta-blockers46.7 (120)40.7 (66)63.6 (14).103
ACEIs/ARBs78.6 (202)69.1 (112)59.1 (13).025
Reason for ICDNS
 Primary prevention51.3 (132)56.7 (92)54.5 (12)
 Secondary prevention48.8 (125)43.5 (70)45.4 (10)
Type of ICD.112
  Single Chamber30.0 (77)39.5 (64)36.4 (8)
  Dual Chamber59.1 (152)45.7 (74)54.5 (12)
  Biventricular10.9 (28)14.8 (24)9.1 (2)

NS: